Select Page

GW Pharma’s cannabis drug OK’d by European Medicines Agency panel

by Jul 26, 2019News0 comments

GW Pharmaceuticals announced that the Committee for Medicinal Products for Human Use (CHMP) recommended approval of the British company’s cannabis-based medicine Epidiolex. The CHMP is responsible for preparing the European Medicines Agency (EMA)’s opinions on questions related to the marketing of human medicines. The CHMP opinion was adopted July 25, and the final decision now rests […]

GW Pharma’s cannabis drug OK’d by European Medicines Agency panel is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

Source: MJ Biz Daily

Like what we’re doing?

Like us on Facebook and share our resources on social media to be informed and share knowledge about Illinois cannabis.